Symbol,AssetType,Name,Description,CIK,Exchange,Currency,Country,Sector,Industry,Address,OfficialSite,FiscalYearEnd,LatestQuarter,MarketCapitalization,EBITDA,PERatio,PEGRatio,BookValue,DividendPerShare,DividendYield,EPS,RevenuePerShareTTM,ProfitMargin,OperatingMarginTTM,ReturnOnAssetsTTM,ReturnOnEquityTTM,RevenueTTM,GrossProfitTTM,DilutedEPSTTM,QuarterlyEarningsGrowthYOY,QuarterlyRevenueGrowthYOY,AnalystTargetPrice,AnalystRatingStrongBuy,AnalystRatingBuy,AnalystRatingHold,AnalystRatingSell,AnalystRatingStrongSell,TrailingPE,ForwardPE,PriceToSalesRatioTTM,PriceToBookRatio,EVToRevenue,EVToEBITDA,Beta,52WeekHigh,52WeekLow,50DayMovingAverage,200DayMovingAverage,SharesOutstanding,SharesFloat,PercentInsiders,PercentInstitutions,DividendDate,ExDividendDate
AMGN,Common Stock,Amgen Inc,"Amgen Inc. is a prominent multinational biopharmaceutical company headquartered in Thousand Oaks, California, renowned for its innovative therapies rooted in recombinant DNA technology. Specializing in oncology, nephrology, and inflammation, Amgen leverages its expertise in molecular biology to develop and commercialize biologic products that enhance patient outcomes. With a robust drug pipeline and a strong competitive position in the biotechnology sector, Amgen remains at the forefront of medical advancements, actively addressing global unmet medical needs and maintaining a commitment to improving the quality of life for patients worldwide.",318154.0,NASDAQ,USD,USA,HEALTHCARE,DRUG MANUFACTURERS - GENERAL,"ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, UNITED STATES, 91320-1799",https://www.amgen.com,December,2025-09-30,172238406000.0,16148000000.0,24.76,0.958,10.95,0.0,0.0,12.92,64.96,0.19,0.327,0.0751,0.991,34916999000.0,24217999000.0,12.92,0.92,0.094,311.69,3.0,10.0,15.0,2.0,1.0,24.76,13.74,4.932,21.55,5.97,13.11,0.461,330.26,247.06,288.09,291.56,538481000.0,536994000.0,0.214,83.731,2025-09-12,2025-11-21
